Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Clinical trial NCT02312934 · COMPLETED

Trial details

NCT number: NCT02312934
Sponsor: Vanderbilt University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chemo Brain Chemotherapy-related Cognitive Impairment Chemo Fog Breast Cancer Chemobrain

Start date: 2015-08-01
Primary completion: 2018-05-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.